Invention:
This invention relates to mechanisms and biomarkers for early detection of potentially aggressive cancers. These biomarkers are useful in determining the aggressiveness and drug resistance of existing cancers.
Background:
There is a need for a better, more convenient way to detect cancers to help reduce unnecessary biopsies and negative treatment side effects.
Applications:
- Early detection of potentially aggressive cancers
- Identification of cancer aggressiveness and drug resistance
- Monitoring disease progress and drug resistance once disease has been diagnosed
Advantages:
- Ability to identify cancer in people prior to exhibiting symptoms
- Determine the mechanism of action driving a disease
- Predict future health outcomes
- An ideal screening test will reduce the risk of death from cancer and lead to a longer overall life
